New Targeted Drug OK'd for Acute Myeloid Leukemia

(MedPage Today) -- The FDA approved quizartinib (Vanflyta) for FLT3 internal tandem duplication (ITD)-positive acute myeloid leukemia (AML), the agency announced on Thursday. Quizartinib is indicated for newly diagnosed patients in combination...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news